DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 06 · Volume 52 · 1984 DOI: 10.1055/s-008-40688

Original Article

  • 221
    Christe, M; Gattlen, P; Fritschi, J; Lämmle, B; Berger, W; Marbet, G A; Duckert, F:

    The Contact Phase of Blood Coagulation in Diabetes Mellitus and in Patients with Vasculopathy

  • 224
    Cederholm-Williams, S A; Rees, Margaret C P; Turnbull, A C:

    Examination of Certain Coagulation Factors in Menstrual Fluid from Women with Normal Blood Loss

  • 226
    Heyns, A du P; Badenhorst, P N; Wessels, P; Pieters, H; Kotzè, H F; Lötter, M G:

    Indium-111-Labelled Human Platelets: A Method for Use in Severe Thrombocytopenia

  • 230
    Seligsohn, U; Rososhansky, S:

    A Glanzmann’s Thrombasthenia Cluster Among Iraqi Jews in Israel

  • 232
    Vallés, Juana; Aznar, Justo; Santos, M Teresa:

    Influence of Some Plasma Fatty Acids on the Phospholipid Fatty Acid Pattern of Human Platelets – An “Ex Vivo” Experience

  • 236
    Fritschi, J; Christe, M; Lämmle, B; Marbet, G A; Berger, W; Duckert, F:

    Platelet Aggregation, β-Thromboglobulin and Platelet Factor 4 in Diabetes Mellitus and in Patients with Vasculopathy

  • 240
    Christe, M; Delley, A; Marbet, G A; Biland, L; Duckert, F:

    Fibrinogen, Factor VIII Related Antigen, Antithrombin III and α2-Antiplasmin in Peripheral Arterial Disease

  • 243
    Izaki, S; Hibino, T; Isozaki, Y; Hsu, P S; Izaki, M; Matsuo, O:

    Plasminogen Activator and Plasminogen Activator Inhibitor Associated with Granulomatous Inflammation: A Study with Murine Leprosy

  • 250
    Sultan, Y; Avner, Ph; Maisonneuve, P; Arnaud, D; Jeanneau, Ch:

    An Immunoradiometric Assay for Factor VIII Related Antigen (VIIIRAg) Using Two Monoclonal Antibodies-Comparison with Polyclonal Rabbit Antibodies for Use in von Willebrand’s Disease Diagnosis

  • 253
    Isles, C; Lowe, G D O; Rankin, B M; Forbes, C D; Lucie, N; Lever, A F; Kennedy, A C:

    Abnormal Haemostasis and Blood Viscosity in Malignant Hypertension

  • 256
    Steinbuch, M; Péjaudier, L; Kichenin, V; Boffa, M C:

    Studies on Prothrombin Complex Concentrates Contact Factors, Complement Components and Proteinase Inhibitors

  • 263
    Viganò, S; Mannucci, P M; D’Angelo, A; Gelfi, C; Gensini, G F; Rostagno, C; Serneri, G G Neri:

    Protein C Antigen Is Not an Acute Phase Reactant and Is often High in Ischemic Heart Disease and Diabetes

  • 267
    Takahashi, Hoyu; Shibata, Akira:

    Agglutination of Formalin-Fixed, Platelet-Type von Willebrand’s Disease Platelets by Human von Willebrand Factor

  • 271
    Taylor, M Ann; Anstee, D J:

    The Use of Functional and Quantitative Assays to Study Glycoprotein Ib in Platelets Stored Under Various In Vitro Conditions

  • 276
    Schulman, Sam; Lockner, Dieter; Bergström, Kurt; Blombäck, Margareta:

    Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis

  • 281
    Moran, D M; Standring, R; Lavender, E A; Harris, G S:

    Assessment of Anti-Streptokinase Antibody Levels in Human Sera Using a Microradioimmunoassay Procedure

  • 288
    Hunter, N R; Dawes, J; MacGregor, I R; Pepper, D S:

    Quantitation by Radioimmunoassay of Thrombospondin Synthesised and Secreted by Human Endothelial Cells

  • 292
    Yamamoto, Koichiro; Sekiguchi, Eisuke; Takatani, Osamu:

    Abnormalities of Epinephrine-Induced Platelet Aggregation and Adenine Nucleotides in Myeloproliferative Disorders

  • 297
    Douste-Blazy, Ph; Sié, P; Boneu, B; Marco, J; Eche, N; Bernadet, P:

    Exercise-Induced Platelet Activation in Myocardial Infarction Survivors with Normal Coronary Arteriogram

  • 301
    Gugliotta, L; Viganò, Silvana; D’Angelo, A; Guarini, Anna; Tura, S; Mannucci, P M:

    High Fibrinopeptide A (FPA) Levels in Acute Non-Lymphocytic Leukemia Are Reduced by Heparin Administration

  • 305
    Matsuo, T; Shinomiya, K; Okuno, S; Matsuo, C; Matsuo, O:

    Urinary Excretion Rate of Antithrombin III Related Antigen in Cerebral Stroke

  • 308
    Lijnen, H R; Marafino, B J; Collen, D:

    In Vitro Fibrinolytic Activity of Recombinant Tissue-Type Plasminogen Activator in the Plasma of Various Primate Species

  • 311
    Brommer, E J P; Schicht, I; Wijngaards, G; Verheijen, J H; Rijken, D C:

    Fibrinolytic Activators and Inhibitors in Terminal Renal Insufficiency and in Anephric Patients

  • 315
    Stegnar, Mojca; Chen, James P:

    Progressive Exposure of E-Neoantigen Associated with Degradation of Crosslinked Fibrin by Plasmin In Vitro

  • 321
    Ragni, Margaret V; Lewis, Jessica H; Spero, Joel A; Bontempo, Franklin A:

    Plasma Fibronectin Levels in Clinical Disease States and After Cryoprecipitate Infusion

  • 325
    Andes, W Abe; Noveck, Robert J; Fleming, J S:

    Inhibition of Platelet Production Induced by an Antiplatelet Drug, Anagrelide, in Normal Volunteers

  • 329
    Oedekoven, B; Bey, R; Mottaghy, K; Schmid-Schönbein, H:

    Gabexate Mesilate (Foy®) as an Anticoagulant in Extracorporeal Circulation in Dogs and Sheep

  • 333
    Steen, Vider M; Holmsen, Holm:

    Inhibition of ADP-Induced Responses in Human Platelets by Agents Elevating the Cyclic AMP Level: Comparison of Aggregation and Shape Change

  • 336
    Thomson, Jean M; Tomenson, J A; Poller, L:

    The Calibration of the Second Primary International Reference Preparation for Thromboplastin (Thromboplastin, Human, Plain, Coded BCT/253)

  • 343
    Rodeghiero, F; Barbui, T; Belin-Peruffo, A Dal; Dini, E:

    Defective Fibrin Crosslinking in Acute Leukemia

  • 347
    Traas, Daan W; Nobel, Bep Hoegee-de; Nieuwenhuizen, Willem:

    Factors Influencing the Separation of Glu-Plasminogen Affinity Forms I and II by Affinity Chromatography

  • 350
    Voorthuizen, H van; Kluft, C:

    Improved Assay Conditions for Automated Antithrombin III Determinations with the Chromogenic Substrate S-2238

  • 354
    Gartner, T Kent; Doyle, Mary Jean; Mosher, Deane F:

    Effect of Anti-Thrombospondin Antibodies on the Hemagglutination Activities of the Endogenous Platelet Lectin and Thrombospondin

    • International Committee Communications

  • 358
    Packham, Marian A:

    Standardization of Collagen: Consideration of Current Practices in Testing Collagen-Induced Aggregation

    • Letter to the Editor

  • 362
    Uszyński, M:

    Heparin Therapy in the Primary Phase of Amniotic Fluid Embolism

  • 363
    Ceriello, Antonio; Curcio, Francesco; Russo, Patrizia Dello; Giugliano, Dario:

    Non-Enzymatic Glycosylation Reduces Antithrombin III Activity

  • 364
    Gresele, Paolo; Houtte, Elisabeth Van; Arnout, Jef; Deckmyn, Hans; Vermylen, Prof. Jos:

    Thromboxane Synthase Inhibition Combined with Thromboxane Receptor Blockade: A Step Forward in Antithrombotic Strategy?

  • 365
    Gaetano, Giovanni de; Cerletti, Chiara; Dejana, Elisabetta; Latini, Roberto; Villa, Silvia:

    The “Aspirin Dilemma”: New Points for Discussion

  • 366
    Gallimore, M J; Friberger, P:

    Prekallikrein Activator

  • 366
    Lämmle, B:

    Prekallikrein Activator - Reply

  • 367
    Abbott, J M; Sutherland, C J; Watt, D A L:

    The Effects of Catecholamines on Circulating Levels of Antithrombin III in the Rat

  • 368
    Maffei, F H A; Fabris, V E; Gregorio, E A; Valeri, V:

    Surgical Trauma and Venous Thrombosis in Total Hip Replacement

  • 369
    Endo, Yasuyuki; Mamiya, Shigeo; Niitsu, Hidetaka; Miura, Akira; Nishimura, Shigeki:

    Reduced Platelet Aggregation Induced by Epinephrine and Idiopathic Thrombocytopenic Purpura in Hereditary Haemorrhagic Teleangiectasia